Literature DB >> 33498321

Interaction of Intestinal Bacteria with Human Rotavirus during Infection in Children.

Roberto Gozalbo-Rovira1,2, Antonio Rubio-Del-Campo1,2, Cristina Santiso-Bellón1, Susana Vila-Vicent1, Javier Buesa1,3, Susana Delgado4,5, Natalia Molinero4,5, Abelardo Margolles4,5, María Jesús Yebra2, María Carmen Collado2, Vicente Monedero2, Jesús Rodríguez-Díaz1,3.   

Abstract

The gut microbiota has emerged as a key factor in the pathogenesis of intestinal viruses, including enteroviruses, noroviruses and rotaviruses (RVs), where stimulatory and inhibitory effects on infectivity have been reported. With the aim of determining whether members of the microbiota interact with RVs during infection, a combination of anti-RV antibody labeling, fluorescence-activated cell sorting and 16S rRNA amplicon sequencing was used to characterize the interaction between specific bacteria and RV in stool samples of children suffering from diarrhea produced by G1P[8] RV. The genera Ruminococcus and Oxalobacter were identified as RV binders in stools, displaying enrichments between 4.8- and 5.4-fold compared to samples nonlabeled with anti-RV antibodies. In vitro binding of the G1P[8] Wa human RV strain to two Ruminococcus gauvreauii human isolates was confirmed by fluorescence microscopy. Analysis in R. gauvreauii with antibodies directed to several histo-blood group antigens (HBGAs) indicated that these bacteria express HBGA-like substances on their surfaces, which can be the target for RV binding. Furthermore, in vitro infection of the Wa strain in differentiated Caco-2 cells was significantly reduced by incubation with R. gauvreauii. These data, together with previous findings showing a negative correlation between Ruminococcus levels and antibody titers to RV in healthy individuals, suggest a pivotal interaction between this bacterial group and human RV. These results reveal likely mechanisms of how specific bacterial taxa of the intestinal microbiota could negatively affect RV infection and open new possibilities for antiviral strategies.

Entities:  

Keywords:  Ruminococcus; gut microbiota; rotavirus

Mesh:

Substances:

Year:  2021        PMID: 33498321      PMCID: PMC7864024          DOI: 10.3390/ijms22031010

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  44 in total

1.  Glycan-modifying bacteria-derived soluble factors from Bacteroides thetaiotaomicron and Lactobacillus casei inhibit rotavirus infection in human intestinal cells.

Authors:  Svetlana Varyukhina; Miguel Freitas; Sabine Bardin; Emilie Robillard; Emmanuelle Tavan; Catherine Sapin; Jean-Pierre Grill; Germain Trugnan
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

2.  Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections.

Authors:  José Antonio Moreno Muñoz; Empar Chenoll; Beatriz Casinos; Esther Bataller; Daniel Ramón; Salvador Genovés; Rebeca Montava; Juan Manuel Ribes; Javier Buesa; Joan Fàbrega; Montserrat Rivero
Journal:  Appl Environ Microbiol       Date:  2011-10-14       Impact factor: 4.792

3.  Therapeutic Opportunities in Intestinal Microbiota-Virus Interactions.

Authors:  Vicente Monedero; María Carmen Collado; Jesús Rodríguez-Díaz
Journal:  Trends Biotechnol       Date:  2018-01-24       Impact factor: 19.536

4.  Rotavirus infection induces glycan availability to promote ileum-specific changes in the microbiome aiding rotavirus virulence.

Authors:  Melinda A Engevik; Lori D Banks; Kristen A Engevik; Alexandra L Chang-Graham; Jacob L Perry; Diane S Hutchinson; Nadim J Ajami; Joseph F Petrosino; Joseph M Hyser
Journal:  Gut Microbes       Date:  2020-05-13

5.  Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity.

Authors:  Robin Uchiyama; Benoit Chassaing; Benyue Zhang; Andrew T Gewirtz
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

6.  Sequence-based analysis of the genus Ruminococcus resolves its phylogeny and reveals strong host association.

Authors:  Alex J La Reau; Jan P Meier-Kolthoff; Garret Suen
Journal:  Microb Genom       Date:  2016-12-12

7.  Rotavirus vaccine protection in low-income and middle-income countries.

Authors:  Girija Ramakrishnan; Jennie Z Ma; Rashidul Haque; William A Petri
Journal:  Lancet Infect Dis       Date:  2019-06-06       Impact factor: 25.071

8.  Infant Early Gut Colonization by Lachnospiraceae: High Frequency of Ruminococcus gnavus.

Authors:  Valeria Sagheddu; Vania Patrone; Francesco Miragoli; Edoardo Puglisi; Lorenzo Morelli
Journal:  Front Pediatr       Date:  2016-06-02       Impact factor: 3.418

9.  Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India.

Authors:  Edward P K Parker; Ira Praharaj; Anna Zekavati; Robin P Lazarus; Sidhartha Giri; Darwin J Operario; Jie Liu; Eric Houpt; Miren Iturriza-Gómara; Beate Kampmann; Jacob John; Gagandeep Kang; Nicholas C Grassly
Journal:  Vaccine       Date:  2017-12-06       Impact factor: 3.641

10.  Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan.

Authors:  Vanessa Harris; Asad Ali; Susana Fuentes; Katri Korpela; Momin Kazi; Jacqueline Tate; Umesh Parashar; W Joost Wiersinga; Carlo Giaquinto; Carolina de Weerth; Willem M de Vos
Journal:  Gut Microbes       Date:  2017-09-29
View more
  6 in total

1.  Effect of early life antibiotic use on serologic responses to oral rotavirus vaccine in the MAL-ED birth cohort study.

Authors:  Denise T St Jean; Elizabeth T Rogawski McQuade; Jessie K Edwards; Peyton Thompson; James Thomas; Sylvia Becker-Dreps
Journal:  Vaccine       Date:  2022-03-25       Impact factor: 4.169

Review 2.  The Rotavirus Vaccine Landscape, an Update.

Authors:  Roberto Cárcamo-Calvo; Carlos Muñoz; Javier Buesa; Jesús Rodríguez-Díaz; Roberto Gozalbo-Rovira
Journal:  Pathogens       Date:  2021-04-26

3.  The Long-Term Impact of Rotavirus Vaccines in Korea, 2008-2020; Emergence of G8P[8] Strain.

Authors:  Kwang Gon Kim; Hye-Young Kee; Hye Jung Park; Jae Keun Chung; Tae Sun Kim; Min Ji Kim
Journal:  Vaccines (Basel)       Date:  2021-04-20

Review 4.  Fucosyltransferase 2: A Genetic Risk Factor for Intestinal Diseases.

Authors:  Mingyang Hu; Xiyun Zhang; Jinze Li; Luotong Chen; Xiaolin He; Tingting Sui
Journal:  Front Microbiol       Date:  2022-07-18       Impact factor: 6.064

5.  Development of a Specific Anti-capsid Antibody- and Magnetic Bead-Based Immunoassay to Detect Human Norovirus Particles in Stool Samples and Spiked Mussels via Flow Cytometry.

Authors:  Ravo M Razafimahefa; Louisa F Ludwig-Begall; Mamadou Amadou Diallo; Benjamin G Dewals; Alain Vanderplasschen; Olivier Nivelles; Caroline Deketelaere; Axel Mauroy; Etienne Thiry
Journal:  Food Environ Virol       Date:  2021-08-07       Impact factor: 2.778

Review 6.  The Role of Host Glycobiology and Gut Microbiota in Rotavirus and Norovirus Infection, an Update.

Authors:  Nazaret Peña-Gil; Cristina Santiso-Bellón; Roberto Gozalbo-Rovira; Javier Buesa; Vicente Monedero; Jesús Rodríguez-Díaz
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.